NUSCIENCE GROUP
InactiveNo longer registered with the KBO; last annual accounts for fiscal year 2024.
Signals
Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024Net result per financial year
1820222324
2018 to 2024 · latest year €-9.44M
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 20-06-2025, 41 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
41 d early
2023
on the day
2022
1 d late
2021
3 d early
2020
11 d late
2019
20 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, full schema
Turnover
€42k▲ 4,413%
2023 · €925
2023: €925
2023 → 2024
EBIT margin
504.9%▼ 24246.3pp
2023 · 24751.2%
2023: 24751.2%
2023 → 2024
Net result
€-9.44M▼ 152%
2023 · €-3.75M
2018: €16.81M
2020: €2k
2022: €3.31M
2023: €-3.75M
2018 → 2024
Working capital
€2.96M
2023 · €-402k
2018: €5.57M
2020: €643k
2022: €-604k
2023: €-402k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20182020202220232024Trend
Turnover€925€42k▲ 4,413%
Equity€104.72M-€93.29M▼ 10.9%€97.30M▲ 4.3%€93.55M▼ 3.9%€84.10M▼ 10.1%
Operating result€10.68M-€51k▼ 99.5%€-64k€229k€211k▼ 7.9%
Net result€16.81M-€2k▼ 100.0%€3.31M▲ 192,051%€-3.75M€-9.44M▼ 152%
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 8% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €85.54M
Fixed assets
€81.14M▼ 13.6%
Current assets
€4.39M▲ 453%
Equity and liabilities €85.54M
Equity
€84.10M▼ 10.1%
Debt
€1.43M▲ 19.8%
The debt ratio rises from 1.3% to 1.7%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€218k▼
2023 · €230k
Cash flow
€-9.43M▼
2023 · €-3.75M
Solvency
98.3%▼
2023 · 98.7%
Current ratio
3.06▲
2023 · 0.66
Quick ratio
3.06▲
2023 · 0.66
Debt / equity
0.02▲
2023 · 0.01
ROE
-11.2%▼
2023 · -4.0%
ROA
-11.0%▼
2023 · -4.0%
Interest coverage
44.50▲
2023 · 28.20
Debt
€1.43M▲
2023 · €1.20M
Debt ≤ 1 year
€1.43M▲
2023 · €1.20M
Income taxes
€159k▼
2023 · €224k
Staff costs
€1.77M▼
2023 · €2.03M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€94.74M€85.54M▼
Fixed assets21/28€93.95M€81.14M▼
Tangible fixed assets22/27€9k€959▼
Land and buildings22€0-
Other tangible fixed assets26€9k€959▼
Financial fixed assets28€93.94M€81.14M▼
Affiliated companies280/1€93.94M€81.14M▼
Participating interests280€93.94M€81.14M▼
Other financial fixed assets284/8€0-
Amounts receivable and cash guarantees285/8€0-
Current assets29/58€795k€4.39M▲
Amounts receivable after more than one year29€42k€42k=
Other amounts receivable291€42k€42k=
Amounts receivable within one year40/41€504k€4.15M▲
Trade receivables40€41k€164k▲
Other amounts receivable41€463k€3.99M▲
Cash at bank and in hand54/58€0-
Deferred charges and accrued income490/1€249k€200k▼
Equity and liabilities
Total equity and liabilities10/49€94.74M€85.54M▼
Equity10/15€93.55M€84.10M▼
Contributions10/11€91.40M€91.40M=
Capital10€91.40M€91.40M=
Issued capital100€91.40M€91.40M=
Reserves13€2.75M€2.75M=
Non-distributable reserves130/1€2.75M€2.75M=
Legal reserve130€2.75M€2.75M=
Profit (loss) carried forward14€-606k€-10.05M▼
Amounts payable17/49€1.20M€1.43M▲
Amounts payable within one year42/48€1.20M€1.43M▲
Trade debts44€577k€929k▲
Suppliers440/4€577k€929k▲
Taxes, remuneration and social security45€620k€505k▼
Taxes450/3€18k€182k▲
Remuneration and social security454/9€602k€323k▼
Accrued charges and deferred income492/3€225€225=
Income statement
Code20232024
Operating income70/76A€4.72M€3.58M▼
Turnover70€925€42k▲
Other operating income74€4.72M€3.54M▼
Operating charges60/66A€4.49M€3.37M▼
Services and other goods61€2.43M€1.58M▼
Remuneration, social security and pensions62€2.03M€1.77M▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€957€8k▲
Other operating charges640/8€31k€7k▼
Operating profit (loss)9901€229k€211k▼
Financial income75/76B€212k€3.31M▲
Recurring financial income75€2k€3.31M▲
Income from financial fixed assets750€2k€3.29M▲
Income from current assets751-€0
Other financial income752/9€220€20k▲
Non-recurring financial income76B€209k-
Financial charges65/66B€3.97M€12.81M▲
Recurring financial charges65€16k€12k▼
Debt charges650€8k€5k▼
Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651-€0
Other financial charges652/9€8k€7k▼
Non-recurring financial charges66B€3.95M€12.80M▲
Profit (loss) for the period before taxes9903€-3.53M€-9.28M▼
Income taxes67/77€224k€159k▼
Taxes670/3€224k€159k▼
Tax adjustments and reversals of tax provisions77-€0
Profit (loss) for the period9904€-3.75M€-9.44M▼
Profit (loss) for the period to be appropriated9905€-3.75M€-9.44M▼
Appropriation of the result
Profit (loss) to be appropriated9906€-606k€-10.05M▼
Profit (loss) brought forward from the previous period14P€3.14M€-606k▼
Social balance
Average headcount (FTE)908715.512.2▼
The notes to these accounts (38 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
20-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
19-02
State Gazette act
General meeting · Merger
Dissolution · Director resignation
24-01
State Gazette act
General meeting · Merger
Dissolution · Accounting effect · Stijn Raes
2024
31-12
Financial
Weakest financial yearnet €-9.44M
Net result drops to €-9.44M, the lowest in the series.
31-12
Financial
Liquidity times 5current ratio 3.06
Current ratio from 0.66 to 3.06.
19-11
State Gazette act
Merger · Corporate purpose
Capital · Accounting effect
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
12-12
State Gazette act
General meeting · Board meeting
Director resignation · Director appointment
01-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 1 day late
2022
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
11-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 11 days late
2020
20-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 20 days late
07-02
State Gazette act
General meeting · Statutes amendment
Corporate purpose · Capital · Stijn RAES
2019
23-10
State Gazette act
General meeting · Director reappointment
Permanent representative · Mandate compensation
31-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
28-06
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
27-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
2016
30-06
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
2013
22-02
State Gazette act
Board meeting · Director reappointment
Permanent representative · General meeting
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Structure & network
Ownership & control
1 partyNUSCIENCE GROUPBE 0478.240.385
controls
Where this company holds controlthis company sits on their board1
2 locations
Acquisitions and mergers
1 transactionTaken over by:Nuscience Belgium
Recognitions · licences · registrations
Legal Entity Identifier
967600ALOU4J2G2HFT91